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Abstract
Background The Japanese Society for Surgery of the
Foot (JSSF) is developing a QOL questionnaire instrument
for use in pathological conditions related to the foot and
ankle. The main body of the outcome instrument (the Self-
Administered Foot Evaluation Questionnaire, SAFE-Q
version 2) consists of 34 questionnaire items, which pro-
vide five subscale scores (1: Pain and Pain-Related; 2:
Physical Functioning and Daily Living; 3: Social Func-
tioning; 4: Shoe-Related; and 5: General Health and Well-
Being). In addition, the instrument has nine optional
questionnaire items that provide a Sports Activity subscale
score. The purpose of this study was to evaluate the test-
retest reliability of the SAFE-Q.
Patients and methods Version 2 of the SAFE-Q was
administered to 876 patients and 491 non-patients, and the
test-retest reliability was evaluated for 131 patients. In
addition, the SF-36 questionnaire and the JSSF Scale scoring
form were administered to all of the participants. Subscale
scores were scaled such that the final sum of scores ranged
between zero (least healthy) to 100 (healthiest).
Results The intraclass correlation coefficients were larger
than 0.7 for all of the scores. The means of the five subscale
scores were between 60 and 75. The five subscales easily
separated patients from non-patients. The coefficients for
the correlations of the subscale scores with the scores on
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the JSSF Scale and the SF-36 subscales were all highly
statistically significantly greater than zero (p \ 0.001). The
means for the five JSSF Scale classification groups fell
within a relatively narrow range, indicating that the SAFE-
Q labels are sufficiently similar to permit their use for all of
the JSSF Scale classifications.
Conclusion The present study revealed that the test-retest
reliability is high for each subscale. Consequently, the
SAFE-Q is valid and reliable. In the future, it will be
beneficial to test the responsiveness of the SAFE-Q.
Introduction
Patient-based outcome instruments, which are used to
measure changes in health status over time, have become
increasingly popular. The four basic types of patient-based
outcome instruments are generic, disease-specific, region-
specific, and patient-specific. A region-specific instrument
contains items specific to only one body part and can be
used with several different disease states affecting a spe-
cific region. The Japanese Society for Surgery of the Foot
(JSSF) is developing a QOL questionnaire for use in
individuals with pathological conditions related to the foot
and ankle as a region-specific outcome instrument.
The questionnaire, named the Self-Administered Foot
Evaluation Questionnaire (hereafter referred to as the ‘‘SAFE-
Q’’) version 1, was subjected to through an initial field test [1],
after which it was revised to a second version [2]. The main
body of the SAFE-Q version 2 consists of 34 questionnaire
items, providing five subscale scores (1: Pain and Pain-Rela-
ted; 2: Physical Functioning and Daily Living; 3: Social
Functioning; 4: Shoe-Related; and 5: General Health and
Well-Being). In addition, the instrument has nine optional
questionnaire items that provide a Sports Activity score.
The SAFE-Q version 2 was subjected to a limited field
test. Tentative scores for the five subscales were compared
to their corresponding scales in the Short Form 36 Health
Survey, version 2.0 (SF-36) [3] and the JSSF Scale score
[4, 5], and the results obtained were reasonable [1].
Therefore, based upon its favorable performance in the
previous field test [2], the JSSF decided to evaluate the
second version of the SAFE-Q further by applying it to a
larger sample of patients with foot and ankle disorders as
well as a control sample of healthy teenagers and adults.
Because the factor structure of the responses to the
instrument was valid in the former study, the primary aim
of the present field survey was to evaluate the test-retest
reliability. A secondary aim was to test the influence of
background factors such as region-specific classification,
age group, and gender on the subscale scores. This report
provides an analysis of the data gathered in this second
field test of the second version of the SAFE-Q.
Patients and methods
Study group
In the present field survey, the SAFE-Q version 2 was
administered to 876 patients with pathological conditions
related to the foot and ankle. A total of 491 non-patients
consisting of healthy teenagers and adult volunteers were
also analyzed. Both patients and non-patients had been
registered in a total of 99 institutions in Japan.
Although the SAFE-Q version 1 has already been pre-
sented in a previous article [1], we have provided the
SAFE-Q version 2 in ‘‘Appendix 1’’ for the sake of reader
convenience. In addition, the manual for the SAFE-Q is
shown in ‘‘Appendix 2.’’
Among the 876 patients, 131 of them with stable path-
ological symptoms attended the test-retest reliability eval-
uation. The same questionnaire form was answered by
these patients twice in succession. The interval between the
first and second tests was a minimum of eight weeks.
When the test was first administered, an SF-36 question-
naire form was also answered by the subjects, and the JSSF
Scale scoring form was recorded by a physician.
Ethical issue
This study was approved by the Life Ethics Committee of
St. Marianna University School of Medicine in 2007 (no.
1192). The elongation of the research period until 2014 was
approved in 2012.
Statistical analysis
EFA and CFA
An exploratory factor analysis (EFA) and confirmatory
factor analysis (CFA) were performed. These were done
to determine whether the factor structure was stable,
given that the patient population in this field test com-
prised a wide variety of pathologies. Response data from
the patients during the first administration (but not the
retest) of this field test were subjected to the same EFA
and CFA as used in the first field test of the second
version.
Computation of subscale scores
Subscale scores were computed for each of the five sub-
scales. To compute the scores, for each subscale, the
average non-missing values of items contributing to the
subscale were computed for each respondent. Prior to
averaging, VAS items were rescaled to conform to the
ranges of the categorical items. Averages were then
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rescaled so that the final sum of scores ranged between zero
(least healthy) and 100 (healthiest), inclusive.
Test-retest reliability
Each subscale’s scores were subjected to a random-effects
linear regression with test-retest as a categorical predictor.
The intraclass correlation coefficient (ICC) was computed
as the index of reliability for each scale. Ninety-five per-
cent confidence intervals (95 % CIs) for ICCs were com-
puted by parametric bootstrapping [6] using 100 bootstrap
samples of patients with scores for the scale for both test
and retest administrations of the questionnaire.
Comparison with JSSF Scale scores
Spearman’s rank correlation coefficients were computed
between the scores for each of the five SAFE-Q subscales
and the JSSF Scale scores (which were only taken from
patient responders during the first administration of the
questionnaire).
Comparison with SF-36 scores
Spearman’s rank correlation coefficients were computed
between the scores for each of the five SAFE-Q subscales
and those for each of the eight SF-36 subscales. Scores for
each of the eight SF-36 subscales were computed using the
Japanese norm-based scoring method as prescribed in the
commercial instrument’s documentation [3]. Again, QOL
scores were only taken from patient responders during the
first administration of the questionnaire.
Comparison of scores for the Pain and Pain-Related
subscale and the SF-36 Bodily Pain subscale
We compared the patients’ scores for the Pain and Pain-
Related subscale with the scores for the SF-36 Bodily
Pain subscale. For this purpose, we extracted the values for
the Pain subscale scores from the JSSF Scale scores. On the
JSSF Pain subscale, 0, 20, 30, and 40 points are assigned to
patients with diseases of the ankle and hindfoot, midfoot,
hallux, and lesser toe, respectively; and 0, 10, 20, or 30 points
are assigned to patients with rheumatoid arthritis. Thus, we
computed the Spearman’s rank correlation coefficient between
the JSSF Pain score and the Pain and Pain-Related score or
SF-36 Bodily Pain score for each of the patient groups.
Background factors
The following patient characteristics were assessed using
scores from the first administration of the questionnaire:
patient group in the JSSF Scale classification, age group, and
gender. Patient groups in the JSSF Scale classification were
as follows: ankle and hindfoot, midfoot, hallux, lesser toe,
and rheumatoid arthritis. Respondents were grouped by age
as follows: 16–39, 40–64, and 65 and older, inclusive. For the
patient groups and patient-age groups, each of the five sub-
scales was assessed by means of one-way analysis of vari-
ance (ANOVA). Gender comparisons were made by means
of Student’s t test in each subgroup of patients classified by
patient group and age group. Dunnett’s multiple compari-
sons test was performed afterward to compare patient
groups. In order to stabilize the variances in the presence of
floor and ceiling effects, the data were arcsine square-root
transformed prior to performing ANOVA or other tests.
Patient versus non-patient comparison
Scores for each of the five subscales were compared
between patients (first administration of the questionnaire)
and non-patients by means of the Mann–Whitney test. This
nonparametric test was used for this comparison due to
concern over the large proportion of ceiling responses in
the healthy group.
Sports items
Sports-related questionnaire items were scored as above,
taking into account the reversal of sense of the VAS item
among them. EFA was applied to the responses of patients
during the first administration of the questionnaire in order
to confirm the unidimensionality of the scale. The test-
retest reliability of the sum of these items’ scores was
assessed as above.
Statistical probability
In the statistical comparisons, a p value of less than 0.05
was considered statistically significant. Below, for all
p values less than 0.001, we simply state p \ 0.001, even
when the exact value was obtained from the computation.
Results
Patient and non-patient classification and age
The classification of the subjects enrolled in the present
field study is summarized in Table 1. A total of 876
patients and 491 non-patients were registered. The majority
of the patients had diseases of the ankle and hindfoot (469).
Numbers of patients in the lesser toe (45) and midfoot (68)
groups were less than 100. The JSSF region-specific clas-
sification was not reported for eight patients. The mean age
of the patients in each group and that of the non-patients
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are also indicated in Table 1. As a whole, the mean ages of
the patients and non-patients were 52.6 ± 18.0 (mean ± SD;
n = 876) and 44.6 ± 16.6 (n = 491), respectively.
Factor analysis
The factor structure was remarkably stable, in that factor
loadings and residual variances were essentially the same
as those obtained in the previous field test of the SAFE-Q
version 2 (data not shown). The factor correlation coeffi-
cients resulting from the CFA are summarized in Table 2.
All of the correlations between different subscale factors
were less than 0.9. The maximum coefficient was 0.841,
for the correlation between the Physical Functioning and
Daily Living subscale and the Social Functioning subscale.
Test-retest reliability
The value of the ICC for each of the five subscales is listed
in Table 3. The ICC was always larger than 0.7; even the
minimum 95 % CI lower limit for the Social Functioning
subscale was larger than 0.6. The ICC for the sum of the
subscale scores was 0.85 (with a 95 % CI of 0.81 to 0.89),
which is, as expected, higher than any of the individual
components.
Distribution of subscale scores
The distributions of the subscale scores are illustrated in
Fig. 1. The mean ± SD and median for the five subscales
were as follows: Pain and Pain-Related: 66.0 ± 23.8, 70.1;
Physical Functioning and Daily Living: 69.2 ± 26.2, 75.0;
Social Functioning: 66.3 ± 32.4, 75.0; Shoe-Related:
62.7 ± 30.4, 66.7; General Health and Well-Being:
66.8 ± 29.7, 75.0. The width between the 25th percentile
and the 75th percentile was broad in the Social Function-
ing, Shoe-Related, and General Health and Well-Being
subscales, while smaller widths were observed in the Pain
and Pain-Related and Physical Functioning and Daily
Living subscales. The values of the means were very
similar for the five subscales, ranging from 60 to 70.
Comparison with the JSSF Scale score
The distribution of the JSSF Scale score is illustrated in
Fig. 2. The mean ± SD and median were 69.4 ± 20.9 and
72 (n = 864), respectively. The JSSF score was correlated
with each of the present subscale scores. The Spearman’s
rank correlation coefficients are summarized in Table 4,
where the patients are classified into JSSF patient groups.
The scores for the five subscales display statistically sig-
nificant correlations (p \ 0.001) with the JSSF Scale score,
with rank correlation coefficients ranging from 0.51 to 0.61
(Table 4). This tendency was the same in each group of
patents. However, slightly smaller correlation coefficients
were observed in the lesser toe group containing 45
patients.
SF-36
The Spearman rank correlation coefficients between each
of the five subscales of the SAFE-Q and each of the eight
SF-36 subscales were all statistically significantly different
from zero (p \ 0.001), as summarized in Table 5. The
correlation coefficient for the Pain and Pain-Related sub-
scale was highest with Bodily Pain; the correlation coef-
ficient for the Shoe-Related subscale was highest with
Bodily Pain and Physical Functioning; the correlation
coefficient for the Physical Functioning and Daily Living
subscale was highest with Physical Functioning; the cor-
relation coefficient for the Social Functioning subscale was
highest with Role Physical and Bodily Pain (but nearly as
high with Social Functioning and Physical Functioning);
Table 1 Numbers of patients and non-patients
Patient-group by JSSF
Scale classification
Gender Number Age
Mean ± SD
Patient
Ankle and hindfoot Male 232 47.0 ± 18.6
Female 237 52.6 ± 18.1
Total 469 49.8 ± 18.5
Hallux Male 43 54.9 ± 19.1
Female 126 59.5 ± 15.6
Total 169 58.3 ± 16.6
Lesser toe Male 15 43.7 ± 19.2
Female 30 52.7 ± 17.4
Total 45 49.7 ± 18.3
Midfoot Male 32 44.8 ± 17.3
Female 36 50.7 ± 19.8
Total 68 47.9 ± 18.7
Rheumatoid arthritis Male 30 61.0 ± 14.3
Female 87 59.3 ± 12.1
Total 117 59.8 ± 12.6
Not reported Male 4 31.5 ± 16.9
Female 4 67.8 ± 7.5
Total 8 49.6 ± 22.8
All groups Male 356 48.6 ± 18.8
Female 520 55.4 ± 17.0
Total 876 52.6 ± 18.0
Non-patient
Male 225 45.0 ± 17.0
Female 266 44.2 ± 16.4
Total 491 44.6 ± 16.6
Self-administered foot evaluation 301
123
the correlation coefficient for the General Health and Well-
Being subscale was highest with Bodily Pain. In these
particular patients, the scores obtained with these two
instruments were largely driven by pain and difficulty with
mobility. The mean ± SD of each norm-based [3] SF-36
subscale score are also shown in Table 5. The mean of the
norm-based SF-36 score ranged from 36 to 47 for these
patients, indicating that the patients were somewhat below
average in their health status.
Comparison of scores from the SAFE-Q Pain and Pain-
Related subscale and SF-36 Bodily Pain subscale scores
Results of comparisons of the Spearman rank correlation
coefficients are summarized in Table 6. The Spearman’s
rank correlation coefficients from the Pain and Pain-Rela-
ted subscale were larger than those from the SF-36 Bodily
Pain subscale in all groups of patients. Statistical signifi-
cance (p \ 0.05) was found in the ankle and hindfoot and
the hallux groups.
Patient characteristics
Comparison among patient groups
A comparison of the mean subscale scores and SDs of the
different JSSF patient groups is provided in Fig. 3. The
scores for the five patient groups were statistically signif-
icantly different according to one-way ANOVA, for all
subscales. The p values from ANOVA were smaller than
0.001 for the Physical Functioning and Daily Living and
Fig. 1 Subscale score
distributions. Left and right
rectangle edges indicate the
25th and 75th percentiles.
Vertical lines within the
rectangles show the medians.
Bullet marks indicate the means.
Left and right ends of the
horizontal lines passing through
the rectangles represent the 5th
and 95th percentiles
Table 2 Factor correlation coefficients among five subscales resulting from confirmatory factor analysis
Pain and Pain-Related
(Q1–Q7, Q10, Q11)a
Physical Functioning and
Daily Living (Q12–Q22)
Social
Functioning
(Q23–Q28)
Shoe-Related
(Q8, Q9, Q34)
General
Health and
Well-Being
(Q29–Q33)
Pain and Pain-Related 0.752 (0.016b) 0.647 (0.021) 0.721 (0.022) 0.785 (0.015)
Physical Functioning
and Daily Living
0.841 (0.012) 0.737 (0.021) 0.808 (0.013)
Social Functioning 0.726 (0.023) 0.804 (0.014)
Shoe-Related 0.718 (0.022)
a Q1–Q34 refers to question item numbers (used in ‘‘Appendix 1’’) included in the corresponding subscales
b Value in parentheses is the standard error in the factor correlation coefficient
Table 3 Values of ICC observed for the five subscales
Subscale ICC 95 % CI
Pain and Pain-Related 0.78 0.74–0.83
Physical Functioning and Daily Living 0.83 0.77–0.89
Social Functioning 0.72 0.64–0.79
Shoe-Related 0.81 0.76–0.86
General Health and Well-Being 0.82 0.78–0.87
Sum of scores 0.85 0.81–0.89
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the Shoe-Related subscales, and were between 0.002 and
0.02 for the other subscales. Patients with rheumatoid
arthritis showed the lowest mean values for the five sub-
scales, and the differences between these mean values and
those of other patient groups were sometimes found to be
statistically significant upon performing Dunnett-type
comparison tests, as shown in Fig. 3.
Age and gender
The subscale scores for male and female patients were
compared for three age groups (ages 16–39, ages 40–64,
ages 65 and older, inclusive) in Fig. 4. The size of the
sample analyzed in this work is large enough to allow
subscale-specific comparisons of scores among age groups
and genders. One-way ANOVA revealed that there were
statistically significant differences (p \ 0.001) among the
age groups in all five subscales when only female patients
were considered. When only male patients were consid-
ered, there were no statistical significant differences among
the age groups for any of the subscales aside from the
Physical Functioning and Daily Life subscale (p \ 0.001).
The scores of male and female patients are also compared
in Fig. 4. In all subscales, the male scores were always
higher than the female scores, whichever age group was
considered; the differences between the male and female
scores were sometimes significant, as shown in Fig. 4.
Comparison of the scores of patients and non-patients
As expected, patients scored lower (less healthy) on aver-
age than non-patients on each of the five subscales
(Table 7). The p value from the Mann–Whitney test
comparing patients and non-patients was less than 0.001
for all five subscales. The means and SDs of the five
subscale scores for non-patients are summarized in
Table 8. Older non-patients tended to present lower mean
values than younger non-patients, and female non-patients
Fig. 2 Distribution of the JSSF Scale scores for the present patients
Table 4 Correlations with the JSSF score for the five patient groups
Patient group by JSSF
Scale classification
n Pain and
Pain-Related
Physical Functioning
and Daily Living
Social
Functioning
Shoe-Related General Health
and Well-Being
Ankle and hindfoot 467 0.63 (p \ 0.001) 0.65 (p \ 0.001) 0.57 (p \ 0.001) 0.49 (p \ 0.001) 0.61 (P \ 0.001)
Hallux 167 0.64 (p \ 0.001) 0.50 (p \ 0.001) 0.50 (p \ 0.001) 0.46 (p \ 0.001) 0.52 (p \ 0.001)
Lesser toe 45 0.47 (p = 0.002) 0.52 (p \ 0.001) 0.51 (p = 0.001) 0.48 (p = 0.002) 0.45 (p = 0.004)
Mid foot 68 0.61 (p \ 0.001) 0.69 (p \ 0.001) 0.63 (p \ 0.001) 0.54 (p \ 0.001) 0.58 (p \ 0.001)
Rheumatoid arthritis 117 0.57 (p \ 0.001) 0.64 (p \ 0.001) 0.59 (p \ 0.001) 0.55 (p \ 0.001) 0.56 (p \ 0.001)
All 864 0.61 (p \ 0.001) 0.60 (p \ 0.001) 0.55 (p \ 0.001) 0.51 (p \ 0.001) 0.56 (p \ 0.001)
Table 5 Comparison of scores for subscales of the SAFE-Q version 2 with SF-36 subscale scores
SF-36 subscale (mean ± SD) SAFE-Q subscale
Pain and
Pain-Related
Physical Functioning
and Daily Living
Social
Functioning
Shoe-Related General Health
and Well-Being
Physical functioning (36.2 ± 18.4) 0.505 (p \ 0.001) 0.771 (p \ 0.001) 0.657 (p \ 0.001) 0.520 (p \ 0.001) 0.638 (p \ 0.001)
Role physical (36.9 ± 17.1) 0.422 (p \ 0.001) 0.625 (p \ 0.001) 0.704 (p \ 0.001) 0.436 (p \ 0.001) 0.607 (p \ 0.001)
Bodily pain (42.2 ± 11.8) 0.652 (p \ 0.001) 0.634 (p \ 0.001) 0.684 (p \ 0.001) 0.532 (p \ 0.001) 0.669 (p \ 0.001)
Social Functioning (46.2 ± 14.9) 0.406 (p \ 0.001) 0.579 (p \ 0.001) 0.667 (p \ 0.001) 0.446 (p \ 0.001) 0.592 (p \ 0.001)
General health (46.8 ± 11.5) 0.403 (p \ 0.001) 0.461 (p \ 0.001) 0.409 (p \ 0.001) 0.399 (p \ 0.001) 0.504 (p \ 0.001)
Vitality (47.3 ± 10.5) 0.415 (p \ 0.001) 0.400 (p \ 0.001) 0.450 (p \ 0.001) 0.375 (p \ 0.001) 0.507 (p \ 0.001)
Role emotional (42.3 ± 15.5) 0.442 (p \ 0.001) 0.543 (p \ 0.001) 0.600 (p \ 0.001) 0.416 (p \ 0.001) 0.610 (p \ 0.001)
Mental health (47.7 ± 11.0) 0.408 (p \ 0.001) 0.441 (p \ 0.001) 0.484 (p \ 0.001) 0.380 (p \ 0.001) 0.566 (p \ 0.001)
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tended to present lower mean values than male non-
patients.
Sports items
Optional sports items were responded to by 275 patients
and 197 non-patients. EFA of the resulting patient data
showed that these items contributed to a single major
factor, as seen before (data not shown). The test-retest
reliability for sports items was similar to that observed for
the other sets of items: ICC = 0.76, with a 95 % CI of
0.64–0.87. The mean ± SD of the Sports Activity score
was 45.3 ± 34.2 in patients, and it was 95.7 ± 10.9 in
non-patients. The difference in the mean scores of patients
and non-patients was statistically significant (p \ 0.001).
Discussion
Several patient-based and region-specific outcome instru-
ments for patients with diseases or injuries of the foot and
ankle region, such as the American Academy of Ortho-
paedic Surgeons lower limb outcomes assessment instru-
ments (including the Foot and Ankle Module (AAOS-FA)
[7], Foot and Ankle Ability Measure (FAAM) [8], Foot
Health Status Questionnaire (FHSQ) [9], and Foot Function
Index [10]), have been developed. Recently, a comparison
of the responsiveness of the Manchester–Oxford foot
questionnaire (MOXFQ) with those of the American
Orthopaedic Foot Ankle Society [AOFAS] [11], SF-36
[12], and EuroQol (EQ-5D) [13] assessments following
foot or ankle surgery was published [14]. Although the
MOXFQ is a patient-based outcome measure, it was orig-
inally developed based on interviews with patients who had
foot surgery. In the interviews, however, the Manchester
Foot Pain and Disability Questionnaire (MFPDQ) [15] had
been utilized as a template. In addition, the measurement
properties of the MOXFQ were initially assessed in a
specific group of patients undergoing surgery for hallux
valgus [16, 17]. In this context, there is no new and original
patient-based outcome instrument focusing only on the foot
Table 6 Comparisons of Spearman’s rank correlation coefficients
between the present Pain and Pain-Related subscale score and the SF-
36 Bodily Pain subscale score
JSSF Scale
classification
Rank correlation coefficients in comparisons of Pain
scores by JSSF Scales
SAFE-Q Pain and
Pain-Related
SF-36
Bodily Pain
Significance
Ankle and
hindfoot
0.63 (n = 409) 0.51 (n = 399) p \ 0.05
Hallux 0.68 (n = 163) 0.47 (n = 160) p \ 0.01
Lessor toe 0.58 (n = 44) 0.32 (n = 44) NS
Midfoot 0.66 (n = 68) 0.50 (n = 67) NS
Rheumatoid
arthritis
0.62 (n = 116) 0.47 (n = 113) NS
0 20 40 60 80 100
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
Pain and Pain-Related
Physical Functioning
and Daily Living
Social Functioning
Shoe-Related
General Health and
Well-Being
1: Ankle-hindfoot; 2: Midfoot; 3: Hallux; 4: Lesser Toes; 5: Rheumatoid Arthritis
Score
**
**
**
**
**
**
**
**
**
**
*
*
Fig. 3 Comparison of the
means and SDs of the five
subscale scores among the five
JSSF patient groups: 1 ankle
and hindfoot; 2 midfoot; 3
hallux; 4 lesser toe; and 5
rheumatoid arthritis. Asterisks
(*p \ 0.05; **p \ 0.01)
indicate p values from Dunnett-
type comparisons with the
rheumatoid arthritis group
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and ankle that is similar to the various instruments that
have already been verified to be valid, repeatable, and
reliable.
There are potential advantages and disadvantages asso-
ciated with each of these instruments [18], and there is an
ongoing process whereby evidence is collected to support
0 20 40 60 80 100
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
Subscale Score
Pain and Pain-Related
Physical Functioning and
Daily Living
Social Functioning
Shoe-Related
General Health and
Well-Being
**
**
**
**
**
**
**
Fig. 4 Mean subscale scores
(and their SDs) for each age
group (1 ages 16–39, 2 ages
40–64, 3 ages 65 and older,
inclusive) and gender (open
column male; closed column
female). **p \ 0.01 for
comparisons between genders.
Using ANOVA, the female-only
scores were found to be
significantly different among all
age groups and subscales
(p \ 0.001), but when only
males were considered, only the
Physical Functioning and Daily
Living subscale scores were
only significantly different
among the age groups
Table 7 Comparison of the subscale scores of patients and non-patients
Subscale Patients Non-patients Comparison between
patients and non-patients
25th percentile Median 75th percentile 25th percentile Median
Pain and Pain-Related 47 70 84 94 100 p \ 0.001
Physical Functioning and Daily Living 55 75 92 98 100 p \ 0.001
Social Functioning 42 75 96 100 100 p \ 0.001
Shoe-Related 42 67 92 92 100 p \ 0.001
General Health and Well-Being 45 75 90 100 100 p \ 0.001
Sports Activity 11 34 75 97 100 p \ 0.001
Table 8 Means and SDs of the five subscale scores for non-patients, classified by age and gender
Group Pain and Pain-Related Physical Functioning
and Daily Living
Social Functioning Shoe-Related General Health
and Well-Being
Age groupa 1 96 ± 7 (n = 224) 99 ± 3 (n = 224) 99 ± 5 (n = 224) 94 ± 12 (n = 224) 99 ± 3 (n = 224)
2 95 ± 10 (n = 178) 98 ± 6 (n = 178) 99 ± 7 (n = 177) 92 ± 13 (n = 178) 99 ± 5 (n = 178)
3 94 ± 12 (n = 89) 93 ± 12 (n = 89) 95 ± 12 (n = 88) 91 ± 14 (n = 88) 94 ± 14 (n = 89)
Gender Male 97 ± 7 (n = 225) 98 ± 6 (n = 241) 99 ± 6 (n = 224) 97 ± 7 (n = 224) 98 ± 7 (n = 225)
Female 94 ± 11 (n = 266) 97 ± 7 (n = 266) 98 ± 9 (n = 265) 89 ± 15 (n = 266) 98 ± 7 (n = 266)
a 1 16–39 years old, 2 40–64 years old, 3 65–88 years old
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their use under various conditions. The usefulness of an
outcome instrument is never completely established. There
is currently an urgent need for scientific evaluation of foot
and ankle surgery, which in turn requires the use of
appropriate (patient-based) standard methods of outcome
assessment. In this context, the Japanese Society for Sur-
gery of the Foot (JSSF) is developing a QOL questionnaire
for use in individuals with pathological conditions related
to the foot and ankle as a region-specific outcome
instrument.
The present field test of the second version of the
SAFE-Q replicated the factor structure of the same ver-
sion of the SAFE-Q in its first field test (which had a
smaller patient sample). The test-retest reliability was
high for each of the subscales and for the average of
all subscales. Gender-related differences, observed in
particular for the Shoe-Related subscale and Physical
Functioning and Daily Living subscale, might reflect the
well-known foot-health consequences of women wearing
high-heeled footwear and women’s more fashion-oriented
attitude towards shoes. It is believed by many surgeons
that age-related differences reflect a general decline in
overall health and physical vigor, as well as a general
reduced ability to recover quickly from health-related
problems.
The differences between patient groups were also sta-
tistically significant according to ANOVA. In particular,
patients with rheumatoid arthritis appeared to fare more
poorly than patients in other region-specific categories
(Fig. 3). Nevertheless, the averages for the patient groups
fell in a relatively narrow range, indicating that the SAFE-
Q labels are sufficiently similar to allow their use in all
patient groups.
As expected, the SAFE-Q readily distinguished patients
with foot and ankle disorders from non-patients. The mean
scores on the subscales range between 60 and 75, which
may lead to concern over the sensitivity or dynamic range
of the QOL instrument in these patients. In contrast to this,
the distribution of JSSF scores observed in the patients
implies that most of the patients did not have severe
symptoms (Fig. 2). This is a plausible reason for the
scattered range of mean values observed in the present field
test.
Given the large sample size, the coefficients for the
correlation of the SAFE-Q subscale scores with the JSSF
Scale score were all highly statistically significantly greater
than zero. Likewise, the coefficients of the correlation of
the SAFE-Q subscale scores and SF-36 subscale scores
were statistically significantly greater than zero for the
same reason. Nevertheless, there was a qualitative align-
ment of the two QOL scales when the correlation coeffi-
cient values were examined. The lack of perfect alignment
indicates that the SAFE-Q constructs measured in these
patients are superior to those measured by the corre-
sponding subscales in the more general SF-36 instrument.
It does appear, however, that the scores obtained using both
instruments are largely driven by pain and difficulty with
mobility in these patients.
The nine items of the Sports Activity subscale of the
SAFE-Q consist of questions about very basic performance
of sports activities [8, 19, 20]. Regarding the Sports
Activity subscale, the unidimensionality of the items
remained stable and the difference between patients and
non-patients was apparent. In addition, the test-retest reli-
ability was adequate. Therefore, we will add these nine
items to the responsiveness analysis without changing
them.
As reviewed by Martin and Irrgang [18], validity testing
of QOL outcome instruments should include assessments
of content validity, construct validity, test-retest reliability,
and responsiveness. In our process, content validity was
confirmed for the SAFE-Q version 1 [1] and version 2 [2]
through the various Cronbach a metrics. Regarding con-
struct validity, we ascertained convergence by comparing
the SAFE-Q subscales with the JSSF scales and SF-36
subscales. We also studied the convergence and divergence
[21] by evaluating the results from CFA. That is, we
observed that the factor loading of each questionnaire item
was large for the intended subscale and small for the other
subscales in the previous field study, and similar results
were seen in the present study.
As described above, we were able to verify that the test-
retest reliability was high for each subscale. The compar-
ison of Spearman rank correlation coefficients shown in
Table 6 suggests that the Pain and Pain-Related subscale is
more responsive than the SF-36 Bodily Pain subscale.
However, there is no other clear standard that could be
used to gauge the responsiveness of the other subscales.
Additionally, the responsiveness should be evaluated by
performing a longitudinal study. In the future, it will be
beneficial to test the responsiveness of the present outcome
instrument.
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Appendix 1
Self-Administered Foot Evaluation Questionnaire (SAFE-Q)
Patient Name
Sex Date of Birth
1. Male
2. Female (Month DD, YYYY)
Date When Answered (Month DD, YYYY)
ID Number:
The following questionnaire is intended to ask about the condition of your feet, and what causes 
you difficulties and problems in your daily life. The questionnaire does not only contain questions 
on pain and physical function, but also emotion-related questions. It also asks about how your 
quality of life may be affected by foot disease and/or injury.
We believe that your honest opinion will benefit future foot treatment and footcare aids.
We would appreciate it if you would take the time to answer the questionnaire.
When we use the word “foot,” we here refer to the parts framed by the rectangle in the illustration 
below, that is, the entire part from the shank through the top of the toes; the knees are not 
included.
= = = = = = = Precautions When Filling out the Questionnaire = = = = = = =
[1] Please think back about the last week or month, and then answer the questions.
[2] Each question also gives you an explanation on how to answer the question; please read the 
explanation carefully and give your answer. It will take about 10 minutes to fill out the 
questionnaire although the time varies among individuals.
[3] There are two ways of answering the questions in this questionnaire.
I. Put a tick ( ) in the appropriate box.
II. Put a cross (×) on the line.
The word “foot” in this questionnaire 
refers to the parts framed by the 
rectangle in the left illustration. The 
knees are not included.
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